Jianli Ma

837 total citations
39 papers, 561 citations indexed

About

Jianli Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jianli Ma has authored 39 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Jianli Ma's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (5 papers) and Cancer Genomics and Diagnostics (5 papers). Jianli Ma is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (5 papers) and Cancer Genomics and Diagnostics (5 papers). Jianli Ma collaborates with scholars based in China, United States and United Kingdom. Jianli Ma's co-authors include Qingyuan Zhang, Han Zhang, Jingtong Li, Ding Ma, Wentao Yang, Yi‐Zhou Jiang, Hong Lv, Yi Xiao, Xiaoli Xu and Shen Zhao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Jianli Ma

34 papers receiving 556 citations

Peers

Jianli Ma
Comparison fields: 5 of 83
  • Molecular Biology 268
  • Cancer Research 213
  • Oncology 183
  • Immunology 95
  • Pulmonary and Respiratory Medicine 87
Replace Marco Seehawer with:
Marco Seehawer United States
EunGi Kim South Korea
Yu‐Chen Pei China
Yun‐Song Yang China
Linwei Guo China
Yajie Yin United States
Michael M. Lizardo United States
Daniela Frezzetti Italy
Un-Jung Yun South Korea
Joji Nakayama Japan
Marco Seehawer United States View profile →
Citations per field, relative to Jianli Ma
Jianli Ma · 1×
Citations per year, relative to Jianli Ma
Jianli Ma · 1×

Countries citing papers authored by Jianli Ma

Since Specialization
Citations

This map shows the geographic impact of Jianli Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianli Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianli Ma more than expected).

Fields of papers citing papers by Jianli Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianli Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianli Ma. The network helps show where Jianli Ma may publish in the future.

Co-authorship network of co-authors of Jianli Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jianli Ma. A scholar is included among the top collaborators of Jianli Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianli Ma. Jianli Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 1
4 1
5 0
6 6
7 2
8 2
9 1
10 1
11 5
12 8
13 3
14 9
15 12
16 24
17 6
18 20
19 3
20 26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026